Emerg Infect Dis. 2020 May;26(5):989-992. doi: 10.3201/eid2605.181992.
In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.
在印度,根据国家结核病消除计划,政府为耐多药结核病提供免费治疗;然而,许多患者在其他地方寻求治疗,这是昂贵的。为了确定这些自费支出,我们采访了 40 名疑似患者,发现他们在注册政府项目之前的花费超过了他们的年中位数收入。